Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
Is a |
Product containing butamben (medicinal product) |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
Is a |
Product containing tetracaine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Butamben |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tetracaine (substance) |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
Is a |
benzocain + butamben + tetracainhydrochlorid |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Benzocaine (substance) |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tetracaine hydrochloride |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
Has manufactured dose form |
kutan OG/ELLER transdermal doseringsform |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Butamben |
false |
Inferred relationship |
Some |
|
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
Has manufactured dose form |
A semi-solid dose form consisting of a single-phase in which solids or liquids may be dissolved or dispersed in the base, which may be hydrophilic, hydrophobic or water-emulsifying. |
false |
Inferred relationship |
Some |
|
|